Clinical Trial Update: Inhalation Low Dose Radionuclide Therapy in Treatment COVID-19 [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial of inhalation low-dose radionuclide therapy for COVID-19 and related pneumonia completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia

Snippet

Sponsor: National Medical Research Radiological Centre of the Ministry of Health of Russia | Conditions: Covid19, Pneumonia, Viral | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-07-07